Category Regional Policy

Caribbean IP: Ensure Unending Local Protection Of Traditional Knowledge

In the Caribbean, issues of traditional knowledge in intellectual property are hardly considered to be of special significance to the majority of policymakers and, except for a few pockets of interest groups such as a group of Rastafarians in Jamaica, the average citizen is uninformed on the subject. The protection of the cultural heritage of the region through a normative system of law is exceedingly necessary for the survival of our unique brand of cultural expression, writes Abiola Inniss.

Key IP-Related Personnel Changes In UN, National Agencies

The end of the year is bringing many changes in intellectual property-related policy offices in Geneva and the capitals. Some of these changes include top offices at the World Intellectual Property Organization, the World Health Organization, South African government, United States government, and a global internet body. Intellectual Property Watch Subscribers can read the details here.

Controversy Over New IGF Mandate, UN Role In Internet Governance

A first proposal on the future mandate of the Internet Governance Forum (IGF) is on the agenda this week at the ongoing 65th session of the United Nations General Assembly in New York. A proposal prepared by the Group of 77 and China opts for another five-year mandate for the IGF to discuss internet public policy related issues and embraces the so-called multi-stakeholder principle.

Wikileaks Creator, In Geneva, Denounces US Abuse Of Human Rights

In a police-secured, airless room full of Geneva journalists, Julian Assange, creator and director of Wikileaks, today gave details of what he described as United States abuse of human rights in the Afghanistan and Iraq wars, as well as an alleged muzzling of US press on those subjects. The United States will undergo its first Universal Periodic Review of the Human Rights Council tomorrow.

Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?

Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.